Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1454, 2004-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Thrombolytics: no survival benefit in patients aged > 75 years?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :
Access to resources
Recommend
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
Should Tamoxifen Be Used in Breast Cancer Prevention?
Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. :
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Tamoxifen for breast cancer prophylaxis: where to from here?
Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. :